does medicaid pay for glp 1 drugs As demand weight-loss rises, states grapple with coverage • Missouri Independent Which Weight Loss Meds Are

However, the liraglutide group experienced a decrease in hip and lumbar spine BMD compared to the exercise and placebo groups

Lilys SURMOUNT-OSA trial will begin in March 2024 to evaluate the effect of Mounjaro on sleep apnea

Talk to your doctor about how often you should visit for follow-ups, including regular monitoring and medication adjustments

In the meantime, GLP-1s represent a clinically relevant tool for improving metabolic resilience, reducing systemic inflammatory stress, and supporting long-term physiological function when applied appropriately

Thats also why they should not be used together both act through the same incretin pathway, and combining them adds cost and complexity without added clinical benefit